Qanatpharma

Qanatpharma is a clinical-stage biopharma company focused on microvascular research and medicine, developing therapeutic strategies to address microvascular dysfunction associated with various diseases. Their pipeline includes innovative research utilizing transcriptomic/proteomic approaches and AI/machine-learning strategies to enhance drug identi... fication and design. The company conducts clinical trials, including the Phase 2 LYRIC-HF trial, which explores new applications for existing drugs in treating compromised cerebral blood flow. With a team based in Canada, Germany, and Switzerland, Qanatpharma collaborates with leading scientific and clinical centers to integrate diverse methodologies in their research.Read More